Work

Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine

Year: 2003

Type: article

Source: Vaccine

DOI: 10.1016/s0264-410x(02)00601-1

Author: D Berd

Institution: Thomas Jefferson University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: AUTOLOGOUS HAPTEN MODIFIED VACCINE FOR HUMAN CANCER, G7169538412

OpenAlex ID: W1977891449

FWCI: 0.202

Cites: 9

Cited by: 5

Related to: 10